Financials

  • Market Capitalization 1.6169 B
  • Employee 524
  • Founded 2008
  • CEO Bahija Jallal
  • Website www.immunocore.com
  • Headquarter United Kingdom
  • FIGI BBG00YYCXFB9
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-48.89
Rapporto prezzo/fatturato
4.37

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Notizie